TY - JOUR T1 - Anti-Fibrotic Effects of Ganoderma Lucidum and Praziquantel on Liver Fibrosis of Schistosoma japonicum AU - Xu, Huijuan AU - Zhu, Yangquan AU - Shuai, Lianyun JO - Journal of Animal and Veterinary Advances VL - 11 IS - 13 SP - 2342 EP - 2346 PY - 2012 DA - 2001/08/19 SN - 1680-5593 DO - javaa.2012.2342.2346 UR - https://makhillpublications.co/view-article.php?doi=javaa.2012.2342.2346 KW - Schistosoma japonicum KW -praziquantel KW -ganoderma lucidum KW -fibrosis KW -anti-oxidation AB - Liver fibrosis is the main damage of Schistosoma japonicum (S. japonicum) in chronic and advanced stages. Praziquantel (PZQ) is currently used for all forms of schistosomiasis. Ganoderma Lucidum (GL) as a traditional chinese medicine has been used in many fields such as anti-oxidation, anti-tumorigenesis, immunoloregulation and anti-fibrosis. But the therapy of GL on schistosomiasis and its mechanism were not well revealed. To investigate the anti-fibrotic effects of GL and/or PZQ on S. japonicum-induced liver fibrosis, 60 Kunming mice were infected with S. japonicum repeatedly and treated with Normal Saline (NS), GL, PZQ, GL combined with PZQ, respectively. The results showed that GL treatment could relieve liver injury by decreasing serum Hyaluronic Acid (HA) and Laminin (LN) level and reducing spleen index ameliorating liver injury of infected mice. Researcher also found that the collagen 3 mRNA and TGF-a1 mRNA expression decreased in the mice of GL group and GL combined with PZQ could obtain much better results. Overall the findings revealed that GL can relieve liver fibrosis of S. japonicumespecially when combined with PZQ. ER -